Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ·Healthcare·Biotechnology
$3.26
+1.56%
Mkt Cap $5.67M
No analyst coverage available
We don't have analyst ratings or price target data for Cyclerion Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.